Quarterly Update: Has the worst case scenario for stock markets been averted? (Q4 2023)

In this episode, Alison Savas is joined by Antipodes Chief Investment Officer, Jacob Mitchell.  They discuss key macro and market developments in the fourth quarter of 2023 along with how Antipodes is positioning for the year ahead. Jacob and Alison also provide key insights into the investment case for Oracle Corp (NYSE: ORCL). Key times: Has the Fed pulled off a soft landing? 1:00 The potential for a deterioration in liquidity & headwinds for US equities at the index level: 6:00 Antipodes current portfolio positioning: 12:00  Valuation discipline case study - exiting SAP & holding Oracle*: 16:00 Stock in focus - Oracle Corp (NYSE: ORCL)*: 20:00 *Stock commentary is illustrative only and should not be viewed as a recommendation to buy, hold, or sell any security.